Cellular changes in prostatic carcinoma after treatment with orchidectomy, estramustine phosphate and medroxyprogesterone acetate

Scandinavian Journal of Urology and Nephrology

Volumn 31, Issue 3, 1997, Pages 255-258

  Tomic, Radisa ^a   Ångström, Tord ^a   Ljungberg, Börje ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cellular changes; Estramustine phosphate; Fine needle biopsy; Medroxyprogesterone acetate; Prostate carcinoma

Indexed keywords

ESTRAMUSTINE PHOSPHATE; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER HORMONE THERAPY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TREATMENT OUTCOME;

EID: 0030795889     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599709070343     Document Type: Article

References (13)

1. Bagshaw MD, Gordon RR, Rickard SK. Radiotherapy of prostatic carcinoma: long- or short-term efficacy. Urology 1985; (XXV Suppl): 17-25.
2. Damber J-E, Bergh A, Landström M, Tomic R. Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology. J Urol 1991; 145: 1283-1287.
3. Esposti PL. Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. Scand J Urol Nephrol 1971; 5: 199-209.
4. Franzen S, Giertz G, Zajicek J. Cytolgoical diagnosis of prostatic tumours by transrectal aspitation biopsy: a preliminary report. Br J Urol 1960; 32: 193-196.
5. Grayhack JT, Keeler TC, Koslowski JM. Carcinoma of the prostate. Hormonal therapy. Cancer 1987; (60 Suppl): 589-601.
6. Johansson J-E, Andersson S-O, Holmberg L. High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomized study. Br J Urol 1991; 68: 67-73.
7. Kurth KH, Altwein JE, Skoluda D, Hohenfellner R. Follow-up of irradiated prostatic carcinoma by aspiration biopsy. J Urol 1977; 117: 615-617.
8. Muntzing J, Kirdani RY, Saroff J, et al. Estracyt on R-3327 rat prostatic carcinoma. Urolouy 1977; 10: 439-445.
9. Pardige WM. Transport of protein-bound hormones in tissues in vivo. Endocr Rev 1981; 2: 103-123.
10. Paulson DF. Radiotherapy versus surgery for localized prostatic cancer. Urol Clin North Am 1987; 14: 675-684.
11. Pavone-Macaluso M, de Voogt HJ, Viggiano G, et al. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer. Final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group. J Urol 1986; 136: 624-631.
12. Tomic R, Bergman B, Hietala S-O, Ångström T. Prognostic significance of transrectal fine-needle aspiration biopsy findings after orchiectomy for carcinoma of the prostate. Eur Urol 1985; 11: 378-381.
13. Tomic R, Ljungberg B, Damber J-E. Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma. Scand J Urol Nephrol 1988; 22:15-18.